Diazabicyclononene derivatives and their use as renin inhibitors

Details for Australian Patent Application No. 2004283821 (hide)

Owner Actelion Pharmaceuticals Ltd.

Inventors Bur, Daniel; Richard-Bildstein, Sylvia; Bezencon, Olivier; Remen, Lubos; Weller, Thomas; Sifferlen, Thierry; Fischli, Walter

Agent A J Park

Pub. Number AU-A-2004283821

PCT Pub. Number WO2005/040165

Priority PCT/EP03/11316 13.10.03 EP; PCT/EP03/11316 13.10.03 EP

Filing date 7 October 2004

Wipo publication date 6 May 2005

International Classifications

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/040165 Priority application(s): WO2005/040165

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283822-Glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors

2004283816-Substituted benzylaminoalkylene heterocycles